← All stocks

UroGen Pharma Ltd.

URGN Net selling

CIK 0001668243 #1945 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$2.96M

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$2.96M

3 of 3 sales

Net

−$2.96M

−$2.96M against sales at will

By person

8 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Schoenberg Mark

Chief Medical Officer

—

$2.89M (2)

−$2.89M

59,882

0.1225%

$2.55M

−58.7%

Smith Jason Drew

General Counsel

—

$64.62K (1)

−$64.62K

53,141

0.1087%

$2.26M

+110.7%

Robinson James A. Jr.

Director

—

8,000

0.0164%

$340.32K

—

Degnan Chris

Chief Financial Officer

—

2,280

0.0047%

$96.99K

—

WEN LEANA

Director

—

2,000

0.0041%

$85.08K

—

Wildman Daniel George

Director

—

2,000

0.0041%

$85.08K

—

Holden Stuart

Director

—

2,000

0.0041%

$85.08K

—

BUTITTA CYNTHIA M

Director

—

2,000

0.0041%

$85.08K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Smith Jason Drew

8 Sep 2026

General Counsel

Sell

1,519

$42.54

$64.62K

Schoenberg Mark

8 Sep 2026

Chief Medical Officer

Sell

871

$42.92

$37.38K

Schoenberg Mark

20 Aug 2026

Chief Medical Officer

Sell

60,677

$47.05

$2.85M

What was left out

Form 4 filings counted 4

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 7,001

History held since 29 Nov 2017